Скачать с ютуб Xylazine Meeting October 4, 2023 Part Two в хорошем качестве

Xylazine Meeting October 4, 2023 Part Two

The Foundation partnered with the Food and Drug Administration (FDA) to host "Mitigating Risks from Human Xylazine Exposure." This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research that directly supports the mitigation and reduction of risks associated with human exposure to xylazine